Antifungal susceptibility of Candida isolates at one institution

Journal Article

Print(0)

Medical mycology journal

Med.Mycol.J.

JID: 101562838; 0 (Antifungal Agents); 0 (Echinocandins); 0 (Lipopeptides); 304NUG5GF4 (Itraconazole); 7XU7A7DROE (Amphotericin B); 8VZV102JFY (Fluconazole); D83282DT06 (Flucytosine); JFU09I87TR (Voriconazole); R10H71BSWG (micafungin); ppublish

Japan

1882-0476

PMID: 24682093

eng

Journal Article; IM

DN/JST.JSTAGE/mmj/55.E1 [pii]

Unknown(0)

24682093

Species distribution and antifungal susceptibility of Candida isolates at one institution were evaluated. Detection rates of fungi were examined for 5 years between 2007 and 2011. Sensitivities of fungi to amphotericin B, flucytosine, fluconazole, micafungin, itraconazole, and voriconazole were evaluated in blood culture-positive patients. A total of 3,832 fungal isolates were detected, including Candida albicans 66.5%, Candida glabrata 20.3%, Candida parapsilosis 6.2%, Candida tropicalis 5.5%, and others 1.5%. Candidemia was diagnosed in 131 patients, and C. albicans, C. parapsilosis, C. glabrata, C. tropicalis, and others were present in 42.0%, 27.5%, 16.0%, 8.4%, and 6.1% of these patients, respectively. Voriconazole had the lowest MIC90s against C. albicans and C. parapsilosis (0.015 and 0.25). Micafungin had a low MIC90 against C. glabrata and C. tropicalis. C. albicans was the most common fungus in patients with candidemia. Voriconazole and micafungin were effective against C. albicans. Amphotericin B was effective for C. parapsilosis, and micafungin showed good efficacy against C. glabrata and C. tropicalis.

Katsuragi,S., Sata,M., Kobayashi,Y., Miyoshi,T., Yamashita,Y., Neki,R., Horiuchi,C., Yamanaka,K., Kamiya,C., Iwanaga,N., Tanaka,H., Ikeda,T., Yoshimatsu,J.

National Cerebral and Cardiovascular Center.

http://vp9py7xf3h.search.serialssolutions.com/?charset=utf-8&pmid=24682093

2014